Avandia
Term · Oncology and biomedicine · MLC-T-ONC-000855
A drug that helps control the amount of glucose (sugar) in the blood and is being studied in the prevention and treatment of some types of cancer. Avandia stops cells from growing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of thiazolidinedione and a type of antiangiogenesis agent. Also called rosiglitazone maleate.
| Identifier | MLC-T-ONC-000855 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | rosiglitazone maleate |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000855",
"term": "Avandia",
"field": "Oncology and biomedicine",
"definition": "A drug that helps control the amount of glucose (sugar) in the blood and is being studied in the prevention and treatment of some types of cancer. Avandia stops cells from growing and may prevent the growth of new blood vessels that tumors need to grow. It is a type of thiazolidinedione and a type of antiangiogenesis agent. Also called rosiglitazone maleate.",
"synonyms": [
"rosiglitazone maleate"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/avandia/"
}
Record 3,164 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.